Media
Latest News
Washington, DC- Today, Congressman Frank Pallone, Jr. (NJ-06) released the following statement on the Supreme Court’s decision to affirm lower court rulings that prevent states from blocking Medicaid access for providers like Planned Parenthood.
Pallone is the Ranking Member of the House Energy and Commerce Committee, which has jurisdiction over health care.
Washington, D.C.- Today Congressman Frank Pallone, Jr. (NJ-06) held a roundtable at Monmouth Medical Center (MMC) with administrators and health professionals to discuss investments by the RWJBarnabas Health System in the MMC campus and the center’s growing role as a healthcare leader in New Jersey.
Washington, D.C. – Today, Congressman Frank Pallone, Jr. (NJ-06) blasted the Trump administration’s approval of five Incidental Harassment Authorization (IHA) permits for companies planning to conduct seismic geological and geophysical surveys along the Atlantic coast.
Washington, D.C. – Today, Congressman Frank Pallone, Jr. (NJ-06) led a letter from Members of Congress asking that President Trump halt any efforts to extradite exiled Turkish cleric Fethullah Gülen from the U.S. to Turkey, as has been reported in numerous media outlets.
Washington, DC- Congressman Frank Pallone, Jr. released the following statement on the forced resignation of Jeff Sessions.
Washington, D.C.- Today in New Brunswick, Congressman Frank Pallone, Jr., joined New Brunswick Mayor James Cahill, law enforcement and gun safety advocates to announce new legislation in Congress to prevent the manufacturing of 3-D firearms. The bill would prohibit the sale, manufacturing, import or marketing of incomplete firearm FRAMES, as well as certain gun parts kits.
Washington, D.C.- Today at Robert Wood John Hospital in New Brunswick, Senator Robert Menendez, Congressman Frank Pallone, Jr. (NJ-06), Congressman Donald Payne, Jr.
Washington, D.C. – Energy and Commerce Ranking Member Frank Pallone, Jr. (D-NJ) released the following statement today in response to President Trump’s Medicare prescription drug proposal:


